ImmuCell Corporation Current Liabilities
ImmuCell Corporation (ICCC) had Current Liabilities of $4.44 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $4.44M.
- 2026-03-31: Liabilities, Current $3.91M.
- 2025-12-31: Liabilities, Current $3.98M.
- 2025-09-30: Liabilities, Current $4.00M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.44M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.91M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $3.98M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $4.00M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $4.45M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $3.87M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $4.41M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $4.47M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $4.56M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $4.18M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $4.20M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $3.33M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $4.19M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $3.84M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.07M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.71M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $2.73M 10-Q/A · filed 2022-11-21 | $2.51M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.57M 10-Q/A · filed 2022-11-21 | $2.35M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.53M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $2.17M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.03M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.10M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $2.21M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $1.80M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.38M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $1.86M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $2.50M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $2.23M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.71M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $2.02M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $2.57M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $1.93M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.37M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $1.41M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $2.06M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $3.58M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $4.25M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.76M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $2.06M 10-K · filed 2018-03-29 | |
| 2016-09-30 | $1.05M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.09M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $890.35K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $792.95K 10-K · filed 2017-03-30 | $817.59K 10-K · filed 2016-03-25 |
| 2015-09-30 | $679.89K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $583.81K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $709.24K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $1.01M 10-K · filed 2016-03-25 | |
| 2014-09-30 | $824.63K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $825.68K 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $841.67K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $635.62K 10-K · filed 2015-03-26 | |
| 2013-09-30 | $566.48K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $893.12K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $584.83K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $665.77K 10-K · filed 2014-03-26 | |
| 2012-09-30 | $549.90K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $519.20K 10-Q/A · filed 2012-09-07 | |
| 2012-03-31 | $641.95K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $635.00K 10-K · filed 2013-03-28 | |
| 2011-09-30 | $606.93K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $888.48K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $525.02K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |